The development of a recombinant hepatitis E vaccine HEV 239. (Q34464464)

2 August 2017

1 reference

title

The development of a recombinant hepatitis E vaccine HEV 239. (English)

1 reference

2 August 2017

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25714510%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Xia Ningshao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25714510%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

5

Jun Zhang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25714510%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Shao-Wei Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25714510%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Qinjian Zhao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25714510%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Shu Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25714510%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

1 reference

1 January 2015

1 reference

Human Vaccines & Immunotherapeutics

2 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25714510%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25714510%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

908-914

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25714510%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25714510%20AND%20SRC:MED&resulttype=core&format=json

Comparable quality attributes of hepatitis E vaccine antigen with and without adjuvant adsorption-dissolution treatment

4 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Long-term efficacy of a hepatitis E vaccine.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Hepatitis e vaccine to prevent morbidity and mortality during epidemics

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin(®).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Host immune status and response to hepatitis E virus infection.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Characterization of virus-like particles in GARDASIL® by cryo transmission electron microscopy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Virus-like particle-based human vaccines: quality assessment based on structural and functional properties

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Immunogenicity and safety of hepatitis E vaccine in healthy hepatitis B surface antigen positive adults

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Development of the hepatitis E vaccine: from bench to field.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Characterization of self-assembled virus-like particles of rat hepatitis E virus generated by recombinant baculoviruses

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Structural basis for the neutralization and genotype specificity of hepatitis E virus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Dimerization of Hepatitis E Virus Capsid Protein E2s Domain Is Essential for Virus–Host Interaction

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Hepatitis E: an emerging awareness of an old disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Difference of T cell and B cell activation in two homologous proteins with similar antigenicity but great distinct immunogenicity.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Safety and efficacy of a recombinant hepatitis E vaccine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Virus-like particles: passport to immune recognition

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

6 July 2018

2 references

https://api.crossref.org/works/10.1080%2F21645515.2015.1008870

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

Determination and analysis of the complete genomic sequence of avian hepatitis E virus (avian HEV) and attempts to infect rhesus monkeys with avian HEV.

27 October 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1008870

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1008870

Hepatitis E vaccine development: a 14 year odyssey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1008870

A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1008870

Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1008870

Pairwise antibody footprinting using surface plasmon resonance technology to characterize human papillomavirus type 16 virus-like particles with direct anti-HPV antibody immobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1008870

Correlation between mouse potency and in vitro relative potency for human papillomavirus Type 16 virus-like particles and Gardasil vaccine samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1008870

Evaluation of the thermal stability of Gardasil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1008870

Real time monitoring of antigenicity development of HBsAg virus-like particles (VLPs) during heat- and redox-treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1008870

Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1008870

Safety of the hepatitis E vaccine for pregnant women: a preliminary analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1008870

In vitro versus in vivo concordance: a case study of the replacement of an animal potency test with an immunochemical assay.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514148

In-depth process understanding of RECOMBIVAX HB® maturation and potential epitope improvements with redox treatment: multifaceted biochemical and immunochemical characterization

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25714510

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25714510

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1080/21645515.2015.1008870

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25714510%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25714510%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference